EcoDrugPlus

Mapk Activated Protein Kinase 2b

Ensembl ID : ENSDARG00000018530
Gene Symbol: MAPKAPK2B
5 Cross references
170 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSDARG00000028082
Gene Symbol: MAPKAPK5
13 Enzyme and pathways 5 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2a

Ensembl ID : ENSDARG00000011373
Gene Symbol: MKNK2A
5 Cross references
156 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2b

Ensembl ID : ENSDARG00000015164
Gene Symbol: MKNK2B
5 Cross references
208 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member A

Ensembl ID : ENSDARG00000009779
Gene Symbol: MCL1A
5 Cross references
150 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSDARG00000008363
Gene Symbol: MCL1B
5 Cross references
229 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSDARG00000033443
Gene Symbol: MDM2
32 Enzyme and pathways 5 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSDARG00000070903
Gene Symbol: MET
28 Enzyme and pathways 5 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae)

Ensembl ID : ENSDARG00000003167
Gene Symbol: MLST8
32 Enzyme and pathways 5 Cross references
195 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSDARG00000021383
Gene Symbol: NAALAD2
3 Enzyme and pathways 5 Cross references
340 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSDARG00000010250
Gene Symbol: NQO1
6 Enzyme and pathways 5 Cross references
180 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSDARG00000099558
Gene Symbol: NPC1L1
3 Enzyme and pathways 6 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).